-
Janssen Asks EMA to Approve Oral Ponesimod to Treat Relapsing MS
Janssen is asking the European Medicines Agency to approval ponesimod, an oral, selective S1P receptor 1 modulator, to treat RRMS and active SPMS. Read more here.
What do you think of this news?
Sorry, there were no replies found.
Log in to reply.